Competitive affinity-based proteome profiling and imaging to reveal potential cellular targets of betulinic acid

Haijun Guo1, Jiaqian Xu, Piliang Hao

  • 1College of Pharmacy, Jinan University, Guangzhou, 510632, China. dingke@jnu.edu.cn pharmlzq@jnu.edu.cn.

Chemical Communications (Cambridge, England)
|August 16, 2017
PubMed

Insights

Betulinic acid (BA) shows antitumor promise, but its cancer cell targets are unknown. Researchers created novel photoprobes to identify these targets using proteome profiling and bioimaging.

Area of Science:

  • Natural Products Chemistry
  • Chemical Biology
  • Cancer Research

Background:

  • Betulinic acid (BA), a pentacyclic triterpenoid, exhibits diverse biological activities, including significant antitumor properties.
  • Despite extensive research into its anticancer mechanisms, the specific cellular targets of BA in cancer cells remain largely unidentified.
  • Understanding these targets is crucial for developing more effective BA-based cancer therapies.

Purpose of the Study:

  • To develop novel chemical tools for identifying the cellular targets of betulinic acid in cancer cells.
  • To investigate the molecular interactions of BA within cancer cells using advanced chemical biology techniques.

Main Methods:

  • Synthesis of two novel betulinic acid photoprobes (BA-1 and BA-2) by conjugating minimalist tetrazole and diazirine photo-crosslinkers at the C-3 and C-28 positions.
  • Application of competitive proteome profiling to identify proteins that interact with the photoprobes.
  • Utilization of bioimaging techniques to visualize the cellular localization and interactions of the photoprobes.

Main Results:

  • Successful development and characterization of BA-1 and BA-2 photoprobes based on established structure-activity relationships.
  • Identification of potential cellular targets of betulinic acid through competitive proteome profiling.
  • Bioimaging approaches provided insights into the cellular engagement of the developed photoprobes.

Conclusions:

  • The developed photoprobes serve as valuable tools for elucidating the antitumor mechanisms of betulinic acid.
  • This study provides a foundation for identifying the direct cellular targets of BA, paving the way for targeted cancer drug development.
  • Further research will focus on validating the identified targets and understanding their role in BA-mediated anticancer effects.

Related Concept Videos